Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.54 USD | +0.92% | +9.64% | +5.06% |
10/05 | Cassava Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
08/05 | Cassava Sciences Raises More Than $125 Million From Warrant Distribution | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.06% | 1.12B | |
+7.58% | 111B | |
+11.27% | 106B | |
-12.33% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.60% | 16.81B | |
+38.76% | 12.54B | |
-24.25% | 8.09B |
- Stock Market
- Equities
- SAVA Stock
- News Cassava Sciences, Inc.
- Cassava Sciences Says MRI Data Suggests Simufilam Not Linked to Amyloid-Related Imaging Abnormalities